2023 Speakers

Aarti Jashnani

Principal Scientist

Bristol Myers Squibb

Abderrahman Laadem

Vice President, Head, Early Oncology Development

Daiichi Sankyo

Adam Taylor

Scientist

Defence Science & Technology Laboratory

Ahmed Bassyouni

Independent Consultant

Bassyouni Consulting

Alain Beck

Senior Director

Pierre Fabre Group

Alyson Smith

Director of Cancer Target Discovery

Seagen

Ana Hidalgo Sastre

Director, Translational Sciences

AstraZeneca

Andrea Galbiati

Research Scientist

Philochem

Andreas Pahl

Chief Scientific Officer

Heidelberg Pharma

Anette Weyergang

Senior Scientist

Oslo University Hospital

Anton Rosenbaum

Senior Group Director

AstraZeneca

Arnaud Tiberghien

Associate Director, Chemistry

Bicycle Therapeutics

Ben Shen

Senior Director

Genentech

Benjamin Fabre

Scientist

Sanofi

Benno Ingelse

Director Bioanalysis & Protein Interaction

Byondis

Bin Deng

Senior Scientist

Eisai

Brian Clark

Principal Consultant

GMP Operations Consulting

Carolina Haefliger

Head of Translational Medicine

Debiopharm

Christian Marsolais

Senior Vice President & Chief Medical Officer

Theratechnologies

Christian Rohlff

Chief Executive Officer

Oxford Biotherapeutics

Christoph Antz

Chief Executive Officer

Veraxa Biotech

Claudia De Lorenzo

Professor of Biochemistry

University of Naples Federico

Dan Milano

Director, Process Development

ImmunoGen

Dangshe Ma

Senior Director

Regeneron Pharmaceuticals Inc

David Bramhill

President & Founder

Bramhill Biological Consulting

David Newman

Consultant

NCI at Frederick

Dawn Spiller

Senior Director, Group Manager Regulatory CMC

AstraZeneca

Dorota Roberts

Associate Director, Technical Products

Seagen

Edith Perez

Chief Medical Officer

Bolt Therapeutics

Francesca Zammarchi

Head of Preclinical Pharmacology

ADC Therapeutics

Gerold Meinhardt

Vice President, Global Team Leader, Asset & Portfolio Management

Daiichi Sankyo

Giorgio Salciarini

Marketing & Business Development Manager

BSP Pharmaceuticals

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Greg Thurber

Associate Chair

University of Michigan

Gregory Adams

Chief Scientific Officer

Elucida Oncology

Henner Ebeling

Senior Scientist

Janssen

Hong Ren

Principal Scientist

MSD

Jake Morris

ADC Insight Lead

Beacon

Jan-Oliver Schwabe

Senior Site Manager, External Manufacturing

Roche

Jarrod Longcor

Chief Operating Officer

Cellectar Biosciences

Jimmy Li

Chief Executive Officer

WuXi XDC

Jon Van Dyck

Principal Scientist

Seagen

Jonathan Beadle

Senior Scientist

AstraZeneca

Jonathan Fawcett

Senior Director, Clinical Development

Exelixis

Juergen Scheuenpflug

Global Head, Clinical Biomarkers, Companion Diagnostics

Merck KGaA

Justin Mason-Home

Director

HPAPI Project Services Limited

Lei Zhu

Senior Director, Head of Chemical Process & Supply Development

Mersana Therapeutics

Madhura Deshpande

Research Scientist

Bristol Myers Squibb

Manel Kraiem

Senior Project Manager

Innate Pharma

Manoj Chiney

Director, Clinical Pharmacology

Gilead Sciences

Marisa Schmitt

Director, Bioanalytics

Heidelberg Pharma

Mark Frigerio

Vice President, Chemistry

Bicycle Therapeutics

Martha Neagu

Medical Director

AbbVie

Martina McDermott

Adjunct Assistant Professor

UCLA

Mary Hu

Chief Executive Officer

Shanghai Miracogen

Michael Method

Executive Medical Director

ImmunoGen

Mike Liao

Principal Scientist

Genentech

Mostafa Nakach

Global Head of Process Engineering

Sanofi

Nathan Alves

Director of Translational Research, Assistant Professor

Indiana University School of Medicine

Nathan Ihle

Vice President, Pharmaceutical Operations

Bolt Biotherapeutics

Neki Patel

Associate Principal Scientist

AstraZeneca

Olga Ab

Director, Product Team Lead

ImmunoGen

Paul Bulger

Director, Analytical Research & Development

MSD

Paul Song

Chief Scientific Officer, Research & Development

Genequantum Healthcare

Rakesh Dixit

President, Chief Scientific Officer

Regios Biosciences

Remy Gebleux

Senior Scientist

NBE Therapeutics

Riccardi Sirtori

Head of NBE DMPK IBA

Merck KGaA

Robert Herbst

Vice President, Technical Operations

ImmunoGen

Robert Huang

Chief Executive Officer

Coherent Biopharma

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Romain Bonnot

Partner

ZS Associates

Sam Lawn

Senior Scientist & Group Lead, In Vivo Biology & PK

Zymeworks

Samuele Cazzamalli

Head of Small Molecule Therapeutics

Philochem

Sharsti Sandall

Research Director, Late-Stage Clinical Programs

Seagen

Shawn Novick

Principal Consultant

International Alliance for Biological Standardization

Shuwen Sun

Principal Scientist

MSD

Sonia Jain

Research Associate

Mayo Clinic

Steffen Woell

Prinicpal Scientist

Merck KGaA

Susan Clardy

Associate Director, Analytical CMC

Mersana Therapeutics

Tae Han

Chief Operating Officer & President

ProfoundBio

Torbjörn Gräslund

Professor, Division of Protein Engineering

KTH Royal Institute of Technology

Torsten Hechler

Vice President, ADC Research

Heidelberg Pharma

Trevor Hallam

Chief Scientific Officer & President

Sutro Biopharma

Vijay Chudasama

Professor, Organic Chemistry & Chemical Biology

University College London

Vincent Blot

Senior Scientific Director

AbbVie

William Grossman

Senior Vice President, Oncology Clinical Development, Therapeutic Area Head

Gilead Sciences

Xinfang Li

Chief Executive Officer

MabPlex

Ying Pan

Senior Director, Translational Science & Biomarkers

CStone Pharmaceuticals

Yogita Krishnamachari

Director

MSD

Yutaka Matsuda

ADC Project Manager

Aji Bio-Pharma Services

Zhibo Liu

Assistant Professor & Principal Investigator

Peking University